CANCER IMMUNOTHERAPY INDEX

News Releases

12/21/2021 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

11/17/2021 -  LCINDX Announces Merger Replacement

 

 

11/5/2021 -  Action Relating to bluebird bio's spin-off of 2seventy bio

 

 

06/15/2021 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

12/15/2020 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

06/16/2020 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

12/17/2019 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

06/18/2019 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

12/18/2018 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

6/20/2018 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

3/1/2018 -  LCINDX Announces Merger Replacement

12/21/2017 -  Discussing Immunotherapy on The Bio Report Podcast

 

12/20/2017 -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

10/4/2017 -  LCINDX Announces Merger Replacements

 

 

9/1/2017 -  Discussing CAR-T on Zacks Friday Finish Line Podcast

 

 

6/21/2017 - LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

12/21/2016  -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

8/17/2016  -  Loncar Index Sponsors Episode of Novel Targets Podcast

 

 

6/21/2016  -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

12/16/2015  -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

6/17/2015  -  LCINDX Semi-Annual Rebalance/Reconstitution Notice

 

 

4/7/2015  -  Loncar Investments Launches Cancer Immunotherapy Index

Loncar Investments, LLC : P.O Box 15072, Lenexa, KS  66285 : 913-871-5007 : Not investment advice or a solicitation to buy or sell securities